Ann: Dronabinol Supply Agreement/Sleep Apnoea Trial Update, page-47

Looks like IHL aren't the only ones looking to treat OSA using CBD, or dronabinol for that matter. Would this explain why phase 1 trials aren't neccessary? Because they've already been completed successfully by another company in Israel... Therapix Biosciences

Article here

Interestingly, Dronabinol seems to have also conducted their own trials looking to treat this disorder with their drug. I think it was back in 2017... can't seem to find the article again.

Any thoughts on how this impacts our ability to be first to market with this product?